Cytolytic CD4 cells: Direct mediators in infectious disease and malignancy

被引:123
作者
Brown, Deborah M. [1 ,2 ]
机构
[1] Univ Nebraska, Sch Biol Sci, Lincoln, NE 68583 USA
[2] Nebraska Ctr Virol, Lincoln, NE 68583 USA
关键词
CD4 T cells; Cytotoxicity; IL-2; Perforin; Granzyme B; Viral infection; CD8(+) T-CELLS; BARR-VIRUS INFECTION; EPITHELIAL-CELLS; IN-VIVO; EFFECTOR FUNCTIONS; VIRAL-INFECTION; DENDRITIC CELLS; CORD BLOOD; B-CELLS; PERFORIN;
D O I
10.1016/j.cellimm.2010.02.008
中图分类号
Q2 [细胞生物学];
学科分类号
071009 ; 090102 ;
摘要
CD4 T cells have traditionally been regarded as helpers and regulators of adaptive immune responses; however, a novel role for CD4 T cells as direct mediators of protection against viral infections has emerged. CD4 T cells with cytolytic potential have been described for almost 40 years, but their role in host protection against infectious disease is only beginning to be realized. In this review, we describe the current literature identifying these cells in patients with various infections, mouse models of viral infection and our own work investigating the development of cytolytic CD4 cells in vivo and in vitro. CD4 CTL are no longer considered an artefact of cell culture and may play a physiological role in viral infections such as EBV, CMV, HIV and influenza. Therefore, vaccine strategies aimed at targeting CD4 CTL should be developed in conjunction with vaccines incorporating B cell and CD8 CTL epitopes. (C) 2010 Elsevier Inc. All rights reserved.
引用
收藏
页码:89 / 95
页数:7
相关论文
共 63 条
[21]   INFLUENZA VIRUS-SPECIFIC CD4+ T-HELPER TYPE-2 T-LYMPHOCYTES DO NOT PROMOTE RECOVERY FROM EXPERIMENTAL VIRUS-INFECTION [J].
GRAHAM, MB ;
BRACIALE, VL ;
BRACIALE, TJ .
JOURNAL OF EXPERIMENTAL MEDICINE, 1994, 180 (04) :1273-1282
[22]   EBV latent membrane proteins (LMPs) 1 and 2 as immunotherapeutic targets:: LMP-specific CD4+ cytotoxic T cell recognition of EBV-transformed B cell lines [J].
Haigh, Tracey A. ;
Lin, Xiaorong ;
Jia, Hui ;
Hui, Edwin P. ;
Chan, Anthony T. C. ;
Rickinson, Alan B. ;
Taylor, Graham S. .
JOURNAL OF IMMUNOLOGY, 2008, 180 (03) :1643-1654
[23]   Functionally active virus-specific T cells that target CMV, adenovirus, and EBV can be expanded from naive T-cell populations in cord blood and will target a range of viral epitopes [J].
Hanley, Patrick J. ;
Cruz, Conrad Russell Young ;
Savoldo, Barbara ;
Leen, Ann M. ;
Stanojevic, Maja ;
Khalil, Mariam ;
Decker, William ;
Molldrem, Jeffrey J. ;
Liu, Hao ;
Gee, Adrian P. ;
Rooney, Cliona M. ;
Heslop, Helen E. ;
Dotti, Gianpietro ;
Brenner, Malcolm K. ;
Shpall, Elizabeth J. ;
Bollard, Catherine M. .
BLOOD, 2009, 114 (09) :1958-1967
[24]   Virus-specific CD4+ T cells:: ready for direct attack [J].
Heller, KN ;
Gurer, C ;
Münz, C .
JOURNAL OF EXPERIMENTAL MEDICINE, 2006, 203 (04) :805-808
[25]  
IBRAHIM L, 1993, IMMUNOLOGY, V79, P119
[26]   Effector and memory CD8+ T cell fate coupled by T-bet and eomesodermin [J].
Intlekofer, AM ;
Takemoto, N ;
Wherry, EJ ;
Longworth, SA ;
Northrup, JT ;
Palanivel, VR ;
Mullen, AC ;
Gasink, CR ;
Kaech, SM ;
Miller, JD ;
Gapin, L ;
Ryan, K ;
Russ, AP ;
Lindsten, T ;
Orange, JS ;
Goldrath, AW ;
Ahmed, R ;
Reiner, SL .
NATURE IMMUNOLOGY, 2005, 6 (12) :1236-1244
[27]   Anomalous type 17 response to viral infection by CD8+ T cells lacking T-bet and eomesodermin [J].
Intlekofer, Andrew M. ;
Banerjee, Arnob ;
Takemoto, Naofumi ;
Gordon, Scott M. ;
DeJong, Caitlin S. ;
Shin, Haina ;
Hunter, Christopher A. ;
Wherry, E. John ;
Lindsten, Tullia ;
Reiner, Steven L. .
SCIENCE, 2008, 321 (5887) :408-411
[28]  
JACOBSON S, 1984, J IMMUNOL, V133, P754
[29]   CD4+CD25+ T cells lyse antigen-presenting B cells by Fas-Fas ligand interaction in an epitope-specific manner [J].
Janssens, W ;
Carlier, V ;
Wu, B ;
VanderElst, L ;
Jacquemin, MG ;
Saint-Remy, JMR .
JOURNAL OF IMMUNOLOGY, 2003, 171 (09) :4604-4612
[30]   Persistent depots of influenza antigen fail to induce a cytotoxic CD8 T cell response [J].
Jelley-Gibbs, Dawn M. ;
Dibble, John P. ;
Brown, Deborah M. ;
Strutt, Tara M. ;
McKinstry, K. Kai ;
Swain, Susan L. .
JOURNAL OF IMMUNOLOGY, 2007, 178 (12) :7563-7570